Loomis, Sayles & Company’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-477,809
Closed -$15.8M 943
2021
Q2
$15.8M Buy
477,809
+18,850
+4% +$711K 0.02% 328
2021
Q1
$17.9M Buy
458,959
+209
+0% +$9.81K 0.02% 301
2020
Q4
$20M Buy
+458,750
New +$15.7M 0.03% 256
2020
Q3
Sell
-490,966
Closed -$17.8M 742
2020
Q2
$17.8M Buy
490,966
+37,945
+8% +$1.07M 0.03% 235
2020
Q1
$8.22M Buy
+453,021
New +$9.93M 0.02% 309

Other funds holding ONEM

Loomis, Sayles & Company's ONEM Position: Q3 2021 in Review

Loomis, Sayles & Company sold out of 1Life Healthcare (ONEM) in Q3 2021, closing a stake of 477,809 shares — an estimated $15.8M sold.

Loomis, Sayles & Company first reported a position in ONEM in Q1 2020 and held it in 5 quarters. The position peaked at $20M in Q4 2020. 200 funds tracked by Wall St. Rank hold ONEM as of Q3 2021.

  • Loomis, Sayles & Company reported no remaining 1Life Healthcare position as of Q3 2021 after selling out during the quarter.
  • Loomis, Sayles & Company sold 477,809 1Life Healthcare shares in Q3 2021, an estimated $15.8M.
  • Loomis, Sayles & Company first reported a position in 1Life Healthcare in Q1 2020 and held it in 5 quarters.
  • Loomis, Sayles & Company's 1Life Healthcare position peaked at $20M in Q4 2020.
  • 200 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2021.

Based on Loomis, Sayles & Company's 13F filing for Q3 2021, filed 12 Nov 2021.